{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:34:28Z","timestamp":1792892068863,"version":"4.5.0"},"reference-count":177,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hepatocyte differentiation, proliferation, and apoptosis are affected by growth factors produced in liver. Insulin-like growth factor 1 and 2 (IGF1 and IGF2) act in response to growth hormone (GH). Other IGF family components include at least six binding proteins (IGFBP1 to 6), manifested by both IGFs develop due to interaction through the type 1 receptor (IGF1R). The data based on animal models and\/or in vitro studies suggest the role of IGF system components in cellular aspects of hepatocarcinogenesis (cell cycle progression, uncontrolled proliferation, cell survival, migration, inhibition of apoptosis, protein synthesis and cell growth), and show that systemic IGF1 administration can reduce fibrosis and ameliorate general liver function. In epidemiologic and clinicopathological studies on chronic liver disease (CLD), lowered serum levels, decreased tissue expression of IGF1, elevated production of IGF1R and variable IGF2 expression has been noted, from the start of preneoplastic alterations up to the developed hepatocellular carcinoma (HCC) stage. These changes result in well-known clinical symptoms of IGF1 deficiency. This review summarized the current data of the complex role of IGF system components in the most common CLD (nonalcoholic fatty liver disease, cirrhosis, and hepatocellular carcinoma). Better recognition and understanding of this system can contribute to discovery of new and improved versions of current preventive and therapeutic actions in CLD.<\/jats:p>","DOI":"10.3390\/ijms19051308","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T12:04:50Z","timestamp":1524830690000},"page":"1308","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":253,"title":["Insulin-Like Growth Factor (IGF) System in Liver Diseases"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8290-3497","authenticated-orcid":false,"given":"Agnieszka","family":"Adamek","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Hepatology and Acquired Immunodeficiencies, Poznan University of Medical Sciences, 3 Szwajcarska Str., 61-285 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldona","family":"Kasprzak","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Poznan University of Medical Sciences, 6 Swiecicki Str., 60-781 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1262-3636(07)70133-7","article-title":"Role of the liver in the control of carbohydrate and lipid homeostasis","volume":"30","author":"Postic","year":"2004","journal-title":"Diabetes Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3382\/ps\/pew043","article-title":"Developmental changes of Insulin-like growth factors in the liver and muscle of chick embryos","volume":"95","author":"Liu","year":"2016","journal-title":"Poult. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1530\/eje.0.1400577","article-title":"IGF-I production by adult rat hepatocytes is stimulated by transforming growth factor-alpha and transforming growth factor-beta1","volume":"140","author":"Voci","year":"1999","journal-title":"Eur. J. Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/clinchem\/45.8.1384","article-title":"Serum insulin-like growth factors and insulin-like growth factor-binding proteins: Clinical implications","volume":"45","author":"Rosen","year":"1999","journal-title":"Clin. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3803\/EnM.2017.32.1.11","article-title":"Recent Insights into Insulin-Like Growth Factor Binding Protein 2 Transcriptional Regulation","volume":"32","author":"Shin","year":"2017","journal-title":"Endocrinol. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1210\/edrv-10-1-68","article-title":"Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations","volume":"10","author":"Daughaday","year":"1989","journal-title":"Endocr. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ecl.2012.04.014","article-title":"The insulin-like growth factor system in cancer","volume":"41","author":"Weroha","year":"2012","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1432-1033.1990.tb15595.x","article-title":"Insulin-like growth factors I and II","volume":"190","author":"Humbel","year":"1990","journal-title":"Eur. J. Biochem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"R321","DOI":"10.1530\/ERC-13-0231","article-title":"IGF2 and cancer","volume":"20","author":"Livingstone","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF01671947","article-title":"Human insulin-related DNA sequences map to chromosomes 2 and 11","volume":"12","author":"Rotwein","year":"1986","journal-title":"Somat. Cell Mol. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1677\/joe.0.1720457","article-title":"GH is a regulator of IGF2 promoter-specific transcription in human liver","volume":"172","author":"Ellis","year":"2002","journal-title":"J. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Rotwein, P. (2017). Diversification of the insulin-like growth factor 1 gene in mammals. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0189642"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00467-009-1258-y","article-title":"Gene regulation by growth hormone","volume":"25","author":"Rotwein","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.3892\/or.2014.3505","article-title":"IGF axis and other factors in HPV-related and HPV-unrelated carcinogenesis (review)","volume":"32","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mrrev.2016.08.007","article-title":"Insulin-like growth factor (IGF) axis in cancerogenesis","volume":"772","author":"Kasprzak","year":"2017","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1043-2760(98)00047-2","article-title":"Regulatory actions of insulin-like growth factor-binding proteins","volume":"9","author":"Rechler","year":"1998","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_17","first-page":"77","article-title":"Role of insulin-like growth factor in maintaining normal glucose homeostasis","volume":"62","author":"Clemmons","year":"2004","journal-title":"Horm. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI20660","article-title":"The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity","volume":"113","author":"Clemmons","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_19","first-page":"761","article-title":"The insulin-like growth factor-binding protein (IGFBP) superfamily","volume":"20","author":"Hwa","year":"1999","journal-title":"Endocr. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tem.2009.01.002","article-title":"IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: Implications for metabolic homeostasis","volume":"20","author":"Wheatcroft","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0079-6603(08)60894-6","article-title":"Molecular regulation of insulin-like growth factor-I and its principal binding protein, IGFBP-3","volume":"60","author":"Phillips","year":"1998","journal-title":"Prog. Nucleic Acid. Res. Mol. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1677\/jme.0.0210097","article-title":"Insulin-like growth factor-binding proteins: Functional diversity or redundancy?","volume":"21","author":"Murphy","year":"1998","journal-title":"J. Mol. Endocrinol."},{"key":"ref_23","first-page":"249","article-title":"The insulin-like growth factor I receptor: A key to tumor growth?","volume":"55","author":"Baserga","year":"1995","journal-title":"Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/edrv.22.1.0419","article-title":"The somatomedin hypothesis: 2001","volume":"22","author":"LeRoith","year":"2001","journal-title":"Endocr. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3892\/ijo.2012.1666","article-title":"The insulin-like growth factor (IGF) signaling axis and hepatitis C virus-associated carcinogenesis (review)","volume":"41","author":"Kasprzak","year":"2012","journal-title":"Int. J. Oncol."},{"key":"ref_26","first-page":"9026","article-title":"Role of liver biopsy in nonalcoholic fatty liver disease","volume":"20","author":"Nalbantoglu","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12072-015-9627-z","article-title":"Pattern and profile of chronic liver disease in acute on chronic liver failure","volume":"9","author":"Abbas","year":"2015","journal-title":"Hepatol. Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrgastro.2013.149","article-title":"From NAFLD to NASH to cirrhosis-new insights into disease mechanisms","volume":"10","author":"Wree","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/liv.13676","article-title":"Future therapy for non-alcoholic fatty liver disease","volume":"38","author":"Issa","year":"2018","journal-title":"Liver Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.3748\/wjg.v19.i22.3375","article-title":"What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?","volume":"19","author":"Tarantino","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1210\/jc.2012-3290","article-title":"Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease","volume":"98","author":"Hribal","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Takahashi, Y. (2017). The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071447"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1478-3231.2010.02428.x","article-title":"Insulin-like growth factor-I and the liver","volume":"31","author":"Bonefeld","year":"2011","journal-title":"Liver Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1479-5876-10-224","article-title":"Human conditions of insulin-like growth factor-I (IGF-I) deficiency","volume":"10","author":"Puche","year":"2012","journal-title":"J. Transl. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5493\/wjem.v6.i1.21","article-title":"Hepatocellular carcinoma: Where are we?","volume":"6","author":"Mazzanti","year":"2016","journal-title":"World J. Exp. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12072-007-9007-4","article-title":"Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease","volume":"1","author":"Ichikawa","year":"2007","journal-title":"Hepatol. Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/en.2011-1601","article-title":"Prenatal dexamethasone exposure potentiates diet-induced hepatosteatosis and decreases plasma IGF-I in a sex-specific fashion","volume":"153","author":"Carbone","year":"2012","journal-title":"Endocrinology"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Hogg, K., Wood, C., McNeilly, A.S., and Duncan, W.C. (2011). The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024877"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbrc.2012.05.115","article-title":"GH-independent IGF-I action is essential to prevent the development of nonalcoholic steatohepatitis in a GH-deficient rat model","volume":"423","author":"Nishizawa","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"34605","DOI":"10.1038\/srep34605","article-title":"IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner","volume":"6","author":"Nishizawa","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.prp.2014.08.007","article-title":"Histopathological aspects of liver under variable food restriction: Has the intense one-week food restriction a protective effect on non-alcoholic-fatty-liver-disease (NAFLD) development?","volume":"210","author":"Makovicky","year":"2014","journal-title":"Pathol. Res. Pract."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"De Minicis, S., Agostinelli, L., Rychlicki, C., Sorice, G.P., Saccomanno, S., Candelaresi, C., Giaccari, A., Trozzi, L., Pierantonelli, I., and Mingarelli, E. (2014). HCC development is associated to peripheral insulin resistance in a mouse model of NASH. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0097136"},{"key":"ref_44","first-page":"147","article-title":"Transient Hepatic Overexpression of Insulin-Like Growth Factor 2 Induces Free Cholesterol and Lipid Droplet Formation","volume":"7","author":"Kessler","year":"2016","journal-title":"Front. Physiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.gt.3302858","article-title":"Liver transduction with a simian virus 40 vector encoding insulin-like growth factor I reduces hepatic damage and the development of liver cirrhosis","volume":"14","author":"Vera","year":"2007","journal-title":"Gene Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-8278(97)80026-8","article-title":"Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis","volume":"26","author":"Picardi","year":"1997","journal-title":"J. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/gast.1997.v113.pm9322513","article-title":"Impaired intestinal sugar transport in cirrhotic rats: Correction by low doses of insulin-like growth factor I","volume":"113","author":"Prieto","year":"1997","journal-title":"Gastroenterology"},{"key":"ref_48","first-page":"G37","article-title":"Effect of insulin-like growth factor I on in vivo intestinal absorption of d-galactose in cirrhotic rats","volume":"276","author":"Picardi","year":"1999","journal-title":"Am. J. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0168-8278(98)80211-0","article-title":"Osteopenia in rats with liver cirrhosis: Beneficial effects of IGF-I treatment","volume":"28","author":"Cemborain","year":"1998","journal-title":"J. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.510310308","article-title":"Insulin-like growth factor-I reverts testicular atrophy in rats with advanced cirrhosis","volume":"31","author":"Garcia","year":"2000","journal-title":"Hepatology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.3748\/wjg.v10.i17.2529","article-title":"Hematotesticular barrier is altered from early stages of liver cirrhosis: Effect of insulin-like growth factor 1","volume":"10","author":"Diez","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2007-1190","article-title":"Low doses of insulin-like growth factor I improve insulin resistance, lipid metabolism, and oxidative damage in aging rats","volume":"149","author":"Delgado","year":"2008","journal-title":"Endocrinology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1053\/gast.1997.v113.pm9352873","article-title":"Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis","volume":"113","author":"Garcia","year":"1997","journal-title":"Gastroenterology"},{"key":"ref_54","first-page":"1306","article-title":"Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats","volume":"55","author":"Bartoli","year":"2000","journal-title":"Gut"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0925-4439(01)00045-X","article-title":"Antifibrogenic effect in vivo of low doses of insulin-like growth factor-I in cirrhotic rats","volume":"1536","author":"Muguerza","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/hep.23412","article-title":"Insulin-like growth factor I gene transfer to cirrhotic liver induces fibrolysis and reduces fibrogenesis leading to cirrhosis reversion in rats","volume":"51","author":"Sobrevals","year":"2010","journal-title":"Hepatology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.3748\/wjg.v20.i21.6523","article-title":"IGFBPrP1 induces liver fibrosis by inducing hepatic stellate cell activation and hepatocyte apoptosis via Smad2\/3 signaling","volume":"20","author":"Zhang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/(SICI)1098-2744(199704)18:4<193::AID-MC2>3.0.CO;2-F","article-title":"Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma","volume":"18","author":"Uchida","year":"1997","journal-title":"Mol. Carcinog."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3748\/wjg.v9.i2.267","article-title":"Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis","volume":"9","author":"Wang","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-3163-4-12","article-title":"Characterization of insulin-like-growth factor II (IGF II) mRNA positive hepatic altered foci and IGF II expression in hepatocellular carcinoma during diethylnitrosamine-induced hepatocarcinogenesis in rats","volume":"4","author":"Mukherjee","year":"2005","journal-title":"J. Carcinog."},{"key":"ref_61","first-page":"406","article-title":"Abnormal expression of insulin-like growth factor-II and its dynamic quantitative analysis at different stages of hepatocellular carcinoma development","volume":"7","author":"Qiu","year":"2008","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/labinvest.3780147","article-title":"Analysis of the IGF axis in preneoplastic hepatic foci and hepatocellular neoplasms developing after low-number pancreatic islet transplantation into the livers of streptozotocin diabetic rats","volume":"80","author":"Scharf","year":"2000","journal-title":"Lab. Investig."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/0192623310396905","article-title":"Upregulation of the insulin receptor and type I insulin-like growth factor receptor are early events in hepatocarcinogenesis","volume":"39","author":"Aleem","year":"2011","journal-title":"Toxicol. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.3748\/wjg.v19.i36.6084","article-title":"Overexpression of insulin-like growth factor-I receptor as a pertinent biomarker for hepatocytes malignant transformation","volume":"19","author":"Yan","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_65","first-page":"196","article-title":"Expression and significance of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in hepatocyte steatosis model","volume":"20","author":"Zhang","year":"2012","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/hep.510290632","article-title":"Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: Differential effects on signal transduction pathways","volume":"29","author":"Ridolfi","year":"1999","journal-title":"Hepatology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s10495-011-0634-9","article-title":"Insulin-like growth factor-1 receptor activation prevents hydrogen peroxide-induced oxidative stress, mitochondrial dysfunction and apoptosis","volume":"16","author":"Hao","year":"2011","journal-title":"Apoptosis"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Chavez-Tapia, N.C., Rosso, N., and Tiribelli, C. (2012). Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease. BMC Gastroenterol., 12.","DOI":"10.1186\/1471-230X-12-20"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00535-012-0527-x","article-title":"Inflammation and fibrogenesis in steatohepatitis","volume":"47","author":"Fujii","year":"2012","journal-title":"J. Gastroenterol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/hep.510270513","article-title":"Characterization of the IGF axis components in isolated rat hepatic stellate cells","volume":"27","author":"Scharf","year":"1998","journal-title":"Hepatology"},{"key":"ref_72","first-page":"401","article-title":"Characterization of insulin-like growth factor (IGF)-I-receptor binding sites during in vitro transformation of rat hepatic stellate cells to myofibroblasts","volume":"34","author":"Brenzel","year":"1996","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1210\/endo.138.11.5540","article-title":"Insulin-like growth factors stimulate expression of hepatocyte growth factor but not transforming growth factor beta1 in cultured hepatic stellate cells","volume":"138","author":"Skrtic","year":"1997","journal-title":"Endocrinology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1096\/fj.05-4704fje","article-title":"Hepatocyte proliferation during liver regeneration is impaired in mice with liver-specific IGF-1R knockout","volume":"20","author":"Wendum","year":"2006","journal-title":"FASEB J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1096\/fasebj.9.15.8529831","article-title":"Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration","volume":"9","author":"Fausto","year":"1995","journal-title":"FASEB J."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1126\/science.274.5291.1379","article-title":"Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice","volume":"22","author":"Cressman","year":"1996","journal-title":"Science"},{"key":"ref_77","first-page":"549","article-title":"Hepatic insulin-like growth factor receptor is upregulated by activation of the GSK3B-FOXO3 pathway after partial hepatectomy","volume":"31","author":"Cai","year":"2017","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semcdb.2016.08.008","article-title":"Chasing the recipe for a pro-regenerative immune system","volume":"61","author":"Godwin","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev-physiol-022516-034356","article-title":"Mechanisms of Organ Injury and Repair by Macrophages","volume":"79","author":"Vannella","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0006-291X(88)81186-0","article-title":"Evidence of autocrine regulation in human hepatoma cell lines","volume":"153","author":"Tsai","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1093\/carcin\/19.12.2121","article-title":"Characterization of the insulin-like growth factor axis in a human hepatoma cell line (PLC)","volume":"19","author":"Scharf","year":"1998","journal-title":"Carcinogenesis"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"10137","DOI":"10.3748\/wjg.v21.i35.10137","article-title":"IGF-1 promotes the growth and metastasis of hepatocellular carcinoma via the inhibition of proteasome-mediated cathepsin B degradation","volume":"21","author":"Lei","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3835(98)00044-5","article-title":"Insulin-like growth factor II (IGF-II) secreted from HepG2 human hepatocellular carcinoma cells shows angiogenic activity","volume":"128","author":"Bae","year":"1998","journal-title":"Cancer Lett."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1054\/ghir.2002.0261","article-title":"Diethylnitrosamine induces long-lasting re-expression of insulin-like growth factor II during early stages of liver carcinogenesis in mice","volume":"12","author":"Lahm","year":"2002","journal-title":"Growth Horm. IGF Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1158\/0008-5472.CAN-04-0292","article-title":"Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression","volume":"64","author":"Breuhahn","year":"2004","journal-title":"Cancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/oxfordjournals.jbchem.a021814","article-title":"Antisense oligodeoxynucleotides of IGF-II selectively inhibit growth of human hepatoma cells overproducing IGF-II","volume":"122","author":"Lin","year":"1997","journal-title":"J. Biochem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2010.01.015","article-title":"IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage","volume":"52","author":"Tovar","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.1158\/1078-0432.CCR-08-2980","article-title":"Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor\/HER3\/AKT signaling pathway: Rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma","volume":"15","author":"Baron","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2007.11.026","article-title":"EGCG inhibits activation of the insulin-like growth factor (IGF)\/IGF-1 receptor axis in human hepatocellular carcinoma cells","volume":"262","author":"Shimizu","year":"2008","journal-title":"Cancer Lett."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.bcp.2006.02.006","article-title":"Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells","volume":"71","author":"Huether","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"ref_91","first-page":"5645","article-title":"Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma","volume":"7","author":"Dai","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_92","first-page":"4990","article-title":"Identification and characterization of genes associated with human hepatocellular carcinogenesis","volume":"59","author":"Kondoh","year":"1999","journal-title":"Cancer Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1210\/endo.141.4.7475","article-title":"Insulin-like growth factor I receptor signaling\u2013overlapping or redundant pathways","volume":"141","author":"LeRoith","year":"2000","journal-title":"Endocrinology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1053\/jhep.2002.36160","article-title":"PI3K-FRAP\/mTOR pathway is critical for hepatocyte proliferation whereas MEK\/ERK supports both proliferation and survival","volume":"36","author":"Coutant","year":"2000","journal-title":"Hepatology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.bcp.2004.05.029","article-title":"An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signaling in hepatocarcinogenesis and in the resistance of hepatocellular cells against drug-induced apoptosis","volume":"86","author":"Alexia","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"ref_96","first-page":"21","article-title":"The role of insulin\u2014Like growth factor\u20141 on steatohepatitis","volume":"80","author":"Dal","year":"2017","journal-title":"Acta Gastroenterol. Belg."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"E1640","DOI":"10.1210\/jc.2011-1227","article-title":"Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I","volume":"96","author":"Arturi","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/hepr.12408","article-title":"Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease","volume":"45","author":"Sumida","year":"2015","journal-title":"Hepatol. Res."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Matsumoto, R., Koga, M., Kasayama, S., Fukuoka, H., Iguchi, G., Odake, Y., Yoshida, K., Bando, H., Suda, K., and Nishizawa, H. (2018). Factors correlated with serum insulin-like growth factor-I levels in health check-up subjects. Growth Horm. IGF Res.","DOI":"10.1016\/j.ghir.2018.01.003"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/apa.13685","article-title":"Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents","volume":"106","author":"Liang","year":"2017","journal-title":"Acta Paediatr."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Liang, S., Yu, Z., Song, X., Wang, Y., Li, M., and Xue, J. (2018). Reduced growth hormone secretion is associated with nonalcoholic fatty liver disease in obese children. Horm. Metab. Res.","DOI":"10.1055\/s-0043-124970"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MEG.0b013e32834e8041","article-title":"Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: Association with liver histology","volume":"24","author":"Colak","year":"2012","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1038\/ctg.2016.72","article-title":"The association between IGF-1 levels and the histologic severity of nonalcoholic fatty liver disease","volume":"8","author":"Dichtel","year":"2017","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1080\/00365521.2017.1379556","article-title":"IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD\u2014A pilot study","volume":"52","author":"Stal","year":"2017","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpeds.2014.01.052","article-title":"Insulin-like growth factor-I and -II levels are associated with the progression of nonalcoholic fatty liver disease in obese children","volume":"165","author":"Cianfarani","year":"2014","journal-title":"J. Pediatr."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2169\/internalmedicine.56.7626","article-title":"The Relationship between the growth hormone\/insulin-like growth factor system and the histological features of nonalcoholic fatty liver disease","volume":"56","author":"Chishima","year":"2017","journal-title":"Intern. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11695-007-9087-1","article-title":"IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients","volume":"17","author":"Espejo","year":"2007","journal-title":"Obes. Surg."},{"key":"ref_108","first-page":"20","article-title":"IGF-1 levels in different stages of liver steatosis and its association with metabolic syndrome","volume":"42","author":"Ballarino","year":"2012","journal-title":"Acta Gastroenterol. Latinoam."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2265.2011.04291.x","article-title":"Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH\/IGF-I levels","volume":"77","author":"Fusco","year":"2012","journal-title":"Clin. Endocrinol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"24740","DOI":"10.1038\/srep24740","article-title":"Phosphorylated IGFBP-1 as a non-invasive predictor of liver fat in NAFLD","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EJE-09-0374","article-title":"Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample","volume":"161","author":"Nauck","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/jgh.12437","article-title":"Relationship between serum circulating insulin-like growth factor-1 and liver fat in the United States","volume":"29","author":"Runchey","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Xu, M., Zheng, X.M., Jiang, F., and Qiu, W.Q. (2018). MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease. J. Cell. Biochem.","DOI":"10.1002\/jcb.26776"},{"key":"ref_114","first-page":"814","article-title":"Serum concentrations of insulin-like growth factor-I (IGF-I) in patients with liver cirrhosis","volume":"50","author":"Vyzantiadis","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.3748\/wjg.v10.i18.2740","article-title":"Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis","volume":"10","author":"Wu","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"ref_116","first-page":"245","article-title":"Serum insulin like growth factor-1 (IGF-1) and insulin like growth factor binding protein-3 (IGFBP-3) levels in liver cirrhosis","volume":"18","author":"Unsal","year":"2007","journal-title":"Turk. J. Gastroenterol."},{"key":"ref_117","first-page":"46","article-title":"Insulin growth factor-1 and insulin growth factor binding protein-3 in Egyptian patients with chronic hepatitis C","volume":"3","author":"Raslan","year":"2007","journal-title":"Arch. Med. Sci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.trstmh.2010.01.012","article-title":"The potential role of insulin-like growth factor 1, insulin-like growth factor binding protein 3 and bone mineral density in patients with chronic hepatitis C virus in Cairo, Egypt","volume":"104","author":"Raslan","year":"2010","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2265.2009.03707.x","article-title":"Ascites from patients with alcoholic liver cirrhosis contains higher IGF-I bioactivity than serum","volume":"72","author":"Jeyaratnaganthan","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"ref_120","first-page":"234","article-title":"Alterations of insulin-like growth factor I (IGF-I) and estradiol serum levels in chronic hepatitis C","volume":"16","author":"Adamek","year":"2012","journal-title":"Contemp. Oncol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3892\/ol.2011.546","article-title":"Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection","volume":"3","author":"Aleem","year":"2012","journal-title":"Oncol. Lett."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/cen.12780","article-title":"The risk of osteoporosis in patients with liver cirrhosis: A meta-analysis of literature studies","volume":"84","author":"Lupoli","year":"2016","journal-title":"Clin. Endocrinol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"252","DOI":"10.6002\/ect.2011.0095","article-title":"Serum insulinlike growth factor-1 and its binding protein-3 levels in children with cirrhosis waiting for a liver transplant","volume":"10","author":"Dehghani","year":"2012","journal-title":"Exp. Clin. Transplant."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11102-007-0035-9","article-title":"Normal levels of serum IGF-I: Determinants and validity of current reference ranges","volume":"10","author":"Brabant","year":"2007","journal-title":"Pituitary"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S1665-2681(19)31009-9","article-title":"IGF-I and IGFBP-3 serum levels in patients hospitalized for complications of liver cirrhosis","volume":"12","author":"Ronsoni","year":"2013","journal-title":"Ann. Hepatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e6181","DOI":"10.5812\/hepatmon.6181","article-title":"A survey of correlation between insulin-like growth factor-I (igf-I) levels and severity of liver cirrhosis","volume":"13","author":"Khoshnood","year":"2013","journal-title":"Hepat. Mon."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"50","DOI":"10.20411\/pai.v2i1.183","article-title":"HIV\/HCV Co-infection, Liver Disease Progression, and Age-Related IGF-1 Decline","volume":"2","author":"Quinn","year":"2017","journal-title":"Pathog. Immun."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"57","DOI":"10.12659\/AOT.883819","article-title":"Insulin-like growth factor I correlates with MELD and returns to normal level after liver transplantation","volume":"18","author":"Castro","year":"2013","journal-title":"Ann. Transplant."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/1354750X.2016.1252949","article-title":"Prognostic significance of insulin-like growth factor-I serum levels in acute decompensation of cirrhosis","volume":"22","author":"Colombo","year":"2017","journal-title":"Biomarkers"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/cncr.11002","article-title":"Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: A prospective study","volume":"95","author":"Mazziotti","year":"2002","journal-title":"Cancer"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"240873","DOI":"10.1155\/2014\/240873","article-title":"Relationship between GH\/IGF-1 axis, graft recovery, and early survival in patients undergoing liver transplantation","volume":"2014","author":"Salso","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref_132","first-page":"105","article-title":"Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation","volume":"57","author":"Weber","year":"2002","journal-title":"Horm. Res."},{"key":"ref_133","first-page":"949","article-title":"Serum IGF-1, IGF-2 and IGFBP-3 as parameters in the assessment of liver dysfunction in patients with hepatic cirrhosis and in the diagnosis of hepatocellular carcinoma","volume":"58","author":"Rehem","year":"2011","journal-title":"Hepatogastroenterology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4254\/wjh.v8.i17.739","article-title":"Circulating insulin-like growth factor-binding protein 3 as prognostic biomarker in liver cirrhosis","volume":"8","author":"Correa","year":"2016","journal-title":"World J. Hepatol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0168-8278(02)00049-1","article-title":"Regulation of the growth hormone receptor\/binding protein, insulin-like growth factor ternary complex system in human cirrhosis","volume":"36","author":"Donaghy","year":"2002","journal-title":"J. Hepatol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/sj.bjc.6600777","article-title":"Focal overexpression of insulin-like growth factor 2 by hepatocytes and cholangiocytes in viral liver cirrhosis","volume":"88","author":"Sedlaczek","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_137","first-page":"292","article-title":"Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma","volume":"22","author":"Seo","year":"1995","journal-title":"Gan Kagaku Ryoho"},{"key":"ref_138","first-page":"6844","article-title":"Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis","volume":"48","author":"Cariani","year":"1988","journal-title":"Cancer Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/1751-2980.12126","article-title":"Insulin-like growth factor binding protein-related protein 1 contributes to hepatic fibrogenesis","volume":"15","author":"Guo","year":"2014","journal-title":"J. Dig. Dis."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ghir.2015.05.002","article-title":"The Circulating IGF System in Hepatocellular Carcinoma: The Impact of Liver Status and Treatment","volume":"25","author":"Espelund","year":"2015","journal-title":"Growth Horm. IGF Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"81098","DOI":"10.18632\/oncotarget.19186","article-title":"Serum insulin-like growth factor-1 and its binding protein 3 as prognostic factors for the incidence, progression, and outcome of hepatocellular carcinoma: A systematic review and meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/172460080802300405","article-title":"Association of elevated IGFBP-1 with increased IGF-II concentration in patients with carcinoma of the liver","volume":"23","author":"Nedic","year":"2008","journal-title":"Int. J. Biol. Markers"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/1097-0215(20000701)87:1<118::AID-IJC17>3.0.CO;2-W","article-title":"Insulin-like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in men","volume":"87","author":"Stuver","year":"2000","journal-title":"Int. J. Cancer"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jcla.20320","article-title":"Association of circulating insulin-like growth factor 1 with hepatocellular carcinoma: One cross-sectional correlation study","volume":"24","author":"Su","year":"2010","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1200\/JCO.2011.36.0636","article-title":"Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma","volume":"29","author":"Kaseb","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1158\/1078-0432.CCR-11-2853","article-title":"Serum insulin-like growth factor-1 levels predict outcomes of patients with advanced hepatocellular carcinoma receiving antiangiogenic therapy","volume":"18","author":"Shao","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"21193","DOI":"10.18632\/oncotarget.4176","article-title":"Validation of an IGF-CTP scoring system for assessing hepatic reserve in Egyptian patients with hepatocellular carcinoma","volume":"6","author":"Shehata","year":"2015","journal-title":"Oncotarget"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7314\/APJCP.2015.16.2.613","article-title":"Predictive value of serum insulin-like growth factor-1 in hepatocellular carcinoma","volume":"16","author":"Elmashad","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Lee, D.H., Lee, J.H., Jung, Y.J., Gim, J., Kim, W., Kim, B.G., Lee, K.L., Cho, Y., Yoo, J.J., and Lee, M. (2017). Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0170394"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1158\/1078-0432.CCR-12-3443","article-title":"Serum insulin-like growth factor-I level is an independent predictor of recurrence and survival in early hepatocellular carcinoma: A prospective cohort study","volume":"19","author":"Cho","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Cho, E., Kim, H.C., Lee, J.H., Yoo, J.-J., Choi, W.M., Cho, Y.Y., Lee, M.J., Cho, Y., Lee, D.H., and Lee, Y.B. (2014). Serum insulin-like growth factor-1 predicts disease progression and survival in patients with hepatocellular carcinoma who undergo transarterial chemoembolization. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0090862"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3892\/etm.2015.2949","article-title":"Prognostic significance of serum insulin-like growth factor-1 in patients with hepatocellular carcinoma following transarterial chemoembolization","volume":"11","author":"Liu","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"261","DOI":"10.7754\/Clin.Lab.2016.160732","article-title":"Serum Insulin-Like Growth Factor-1 (IGF-1): A Novel Prognostic Factor for Early Recurrence of Hepatocellular Carcinoma (HCC)","volume":"63","author":"Yao","year":"2017","journal-title":"Clin. Lab."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.3748\/wjg.v11.i30.4655","article-title":"Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma","volume":"11","author":"Dong","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/00365520410009311","article-title":"Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinoma","volume":"40","author":"Tsai","year":"2005","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.ejim.2012.04.014","article-title":"Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma?","volume":"23","author":"Morace","year":"2012","journal-title":"Eur. J. Intern. Med."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1365-2265.2003.01909.x","article-title":"Increased IGF-I: IGFBP-3 ratio in patients with hepatocellular carcinoma","volume":"59","author":"Mattera","year":"2003","journal-title":"Clin. Endocrinol."},{"key":"ref_158","first-page":"174","article-title":"Pilot study of elevated levels of insulin-like growth factor-binding protein-2 as indicators of hepatocellular carcinoma","volume":"60","author":"Ranke","year":"2003","journal-title":"Horm. Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"15125","DOI":"10.1007\/s13277-016-5360-z","article-title":"Insulin-like growth factor-related components and the risk of liver cancer in a nested case-control study","volume":"37","author":"Adachi","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/gcc.22120","article-title":"Methylation of serum insulin-like growth factor-binding protein 7 promoter in hepatitis B virus-associated hepatocellular carcinoma","volume":"53","author":"Li","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_161","first-page":"115","article-title":"A possible role for insulin-like growth factor-binding protein-3 autocrine\/paracrine loops in controlling hepatocellular carcinoma cell proliferation","volume":"13","author":"Huynh","year":"2002","journal-title":"Cell Growth Differ."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3892\/or.2013.2546","article-title":"The insulin-like growth factor-1 and expression of its binding protein-3 in chronic hepatitis C and hepatocellular carcinoma","volume":"30","author":"Adamek","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_163","first-page":"334","article-title":"Differential expression of insulin-like growth factor 1 in human primary liver cancer","volume":"104","author":"Ikeda","year":"2013","journal-title":"Fukuoka Igaku Zasshi"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1477-7819-12-231","article-title":"Expression levels of insulin-like growth factors and receptors in hepatocellular carcinoma: A retrospective study","volume":"12","author":"Chun","year":"2014","journal-title":"World J. Surg. Oncol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.3748\/wjg.v11.i27.4272","article-title":"Expression of albumin, IGF-1, IGFBP-3 in tumor tissues and adjacent non-tumor tissues of hepatocellular carcinoma patients with cirrhosis","volume":"11","author":"Luo","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1007010818094","article-title":"The expression of insulin-like growth factor binding proteins in human hepatocellular carcinoma","volume":"207","author":"Gong","year":"2000","journal-title":"Mol. Cell. Biochem."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.3892\/ol.2017.5934","article-title":"Low expression levels of insulin-like growth factor binding protein-3 are correlated with poor prognosis for patients with hepatocellular carcinoma","volume":"13","author":"Yan","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.1158\/1078-0432.CCR-10-2774","article-title":"Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma","volume":"17","author":"Chen","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ijc.25994","article-title":"IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma","volume":"130","author":"Tomimaru","year":"2012","journal-title":"Int. J. Cancer"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1007\/s13277-013-0912-y","article-title":"Abnormal expression of insulin-like growth factor-I receptor in hepatoma tissue and its inhibition to promote apoptosis of tumor cells","volume":"34","author":"Dong","year":"2013","journal-title":"Tumour Biol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5009\/gnl.2014.8.1.79","article-title":"Prognostic significance of p53, mTOR, c-Met, IGF-1R, and HSP70 overexpression after the resection of hepatocellular carcinoma","volume":"8","author":"Kang","year":"2014","journal-title":"Gut Liver"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.3748\/wjg.v21.i13.3867","article-title":"Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C","volume":"21","author":"Kasprzak","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.3748\/wjg.14.5419","article-title":"Liver insulin-like growth factor 2 methylation in hepatitis C virus cirrhosis and further occurrence of hepatocellular carcinoma","volume":"14","author":"Couvert","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.clinre.2012.06.013","article-title":"Insulin-like growth factor 2 gene methylation in peripheral blood mononuclear cells of patients with hepatitis C related cirrhosis or hepatocellular carcinoma","volume":"36","author":"Couvert","year":"2012","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1245\/s10434-009-0904-8","article-title":"Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma","volume":"17","author":"Weng","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cyto.2014.02.006","article-title":"Impact of insulin-like growth factor 2, insulin-like growth factor receptor 2, insulin receptor substrate 2 genes polymorphisms on susceptibility and clinicopathological features of hepatocellular carcinoma","volume":"68","author":"Rashad","year":"2014","journal-title":"Cytokine"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1478-3231.2011.02648.x","article-title":"Single nucleotide polymorphisms associated with metastatic tumour antigen 1 overexpression in patients with hepatocellular carcinoma","volume":"32","author":"Lee","year":"2012","journal-title":"Liver Int."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/5\/1308\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:02:26Z","timestamp":1760194946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/5\/1308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":177,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5]]}},"alternative-id":["ijms19051308"],"URL":"https:\/\/doi.org\/10.3390\/ijms19051308","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]}}}